Innospec Stock Today

IOSP Stock  USD 129.55  0.69  0.54%   

Performance

5 of 100

 
Low
 
High
Modest

Odds Of Distress

Less than 8

 
100  
 
Zero
Low
Innospec is selling at 129.55 as of the 28th of March 2024; that is 0.54 percent up since the beginning of the trading day. The stock's last reported lowest price was 128.81. Innospec has only a 8 % chance of going through financial distress over the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Innospec are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Materials
IPO Date
13th of May 1998
Category
Basic Materials
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. The company has 24.87 M outstanding shares of which 273.82 K shares are currently shorted by private and institutional investors with about 2.52 trading days to cover. More on Innospec

Moving together with Innospec Stock

  0.73DNMR Danimer Scientific Earnings Call TodayPairCorr
  0.69ECVT Ecovyst Financial Report 2nd of May 2024 PairCorr

Moving against Innospec Stock

  0.77NANX Nanophase Technol Report 3rd of April 2024 PairCorr
  0.41CC Chemours Earnings Call TodayPairCorr

Innospec Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Innospec's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Innospec or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and President and DirectorPatrick Williams
Business ConcentrationSpecialty Chemicals, Basic Materials, SP Small-Cap 600, NASDAQ Composite, NASDAQ Composite Total, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors)
Average Analyst Recommendation
Analysts covering Innospec report their recommendations after researching Innospec's financial statements, talking to executives and customers, or listening in on Innospec's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Innospec. The Innospec consensus assessment is calculated by taking the average forecast from all of the analysts covering Innospec.
Financial Strength
Based on the measurements of operating efficiency obtained from Innospec's historical financial statements, Innospec is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. Financial strength of Innospec is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.04220.0815
Way Down
Slightly volatile
Asset Turnover0.741.1414
Way Down
Very volatile
Gross Profit Margin0.390.2991
Significantly Up
Slightly volatile
Total Current Liabilities233.9 M371.5 M
Way Down
Slightly volatile
Non Current Liabilities Total170.8 M186.3 M
Significantly Down
Very volatile
Total AssetsB1.7 B
Way Down
Slightly volatile
Total Current Assets930 M885.7 M
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities104.4 M205.9 M
Way Down
Pretty Stable
Innospec's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Innospec's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Innospec's financial leverage. It provides some insight into what part of Innospec's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Innospec's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Innospec deploys its capital and how much of that capital is borrowed.
Liquidity
Innospec cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 45.2 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Innospec has a current ratio of 2.12, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innospec until it has trouble settling it off, either with new capital or with free cash flow. So, Innospec's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innospec sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innospec to invest in growth at high rates of return. When we think about Innospec's use of debt, we should always consider it together with cash and equity.

Depreciation

30.61 Million
Innospec (IOSP) is traded on NASDAQ Exchange in USA. It is located in 8310 South Valley Highway, Englewood, CO, United States, 80112 and employs 2,400 people. Innospec is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innospec's market, we take the total number of its shares issued and multiply it by Innospec's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Innospec conducts business under Chemicals sector and is part of Materials industry. The entity has 24.87 M outstanding shares of which 273.82 K shares are currently shorted by private and institutional investors with about 2.52 trading days to cover. Innospec currently holds about 71.4 M in cash with 205.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.88.
Check Innospec Probability Of Bankruptcy
Ownership Allocation
Innospec has a total of 24.87 Million outstanding shares. The majority of Innospec outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innospec to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innospec. Please pay attention to any change in the institutional holdings of Innospec as this could imply that something significant has changed or is about to change at the company. Also note that almost two hundred fourty-eight thousand six hundred eighty invesors are currently shorting Innospec expressing very little confidence in its future performance.
Check Innospec Ownership Details

Innospec Stock Price Odds Analysis

In regard to a normal probability distribution, the odds of Innospec jumping above the current price in 90 days from now is roughly 2.04%. The Innospec probability density function shows the probability of Innospec stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.7243. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Innospec will likely underperform. Additionally, innospec has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 129.55HorizonTargetOdds Above 129.55
97.92%90 days
 129.55 
2.04%
Based on a normal probability distribution, the odds of Innospec to move above the current price in 90 days from now is roughly 2.04 (This Innospec probability density function shows the probability of Innospec Stock to fall within a particular range of prices over 90 days) .

Innospec Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Innospec that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Innospec's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Innospec's value.
InstituionRecorded OnShares
Goldman Sachs Group Inc2023-12-31
496.7 K
Nuveen Asset Management, Llc2023-12-31
464.5 K
Northern Trust Corp2023-12-31
401.4 K
Charles Schwab Investment Management Inc2023-12-31
307.5 K
Amvescap Plc.2023-12-31
287.1 K
Westwood Holdings Group Inc2023-12-31
272 K
Bank Of New York Mellon Corp2023-12-31
263.1 K
Morgan Stanley - Brokerage Accounts2023-12-31
219.4 K
Norges Bank2023-12-31
210.4 K
Blackrock Inc2023-12-31
M
Vanguard Group Inc2023-12-31
M
View Innospec Diagnostics

Innospec Historical Income Statement

Innospec Income Statement is one of the three primary financial statements used for reporting Innospec's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Innospec revenue and expense. Innospec Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Innospec's Net Income Applicable To Common Shares is relatively stable compared to the past year. As of 03/28/2024, Non Recurring is likely to grow to about 49.6 M, while Operating Income is likely to drop slightly above 97.2 M. View More Fundamentals

Innospec Stock Against Markets

Picking the right benchmark for Innospec stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Innospec stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Innospec is critical whether you are bullish or bearish towards Innospec at a given time. Please also check how Innospec's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Innospec without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Innospec Corporate Directors

Innospec corporate directors refer to members of an Innospec board of directors. The board of directors generally takes responsibility for the Innospec's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Innospec's board members must vote for the resolution. The Innospec board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy Innospec Stock?

Before investing in Innospec, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Innospec. To buy Innospec stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Innospec. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Innospec stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Innospec stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Innospec stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Innospec, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Innospec Stock please use our How to Invest in Innospec guide.

Already Invested in Innospec?

The danger of trading Innospec is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Innospec is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Innospec. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Innospec is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Innospec is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Innospec Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Innospec Stock. Highlighted below are key reports to facilitate an investment decision about Innospec Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Innospec Stock analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Innospec's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innospec. If investors know Innospec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innospec listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.48
Dividend Share
1.41
Earnings Share
5.56
Revenue Per Share
78.419
Quarterly Revenue Growth
(0.03)
The market value of Innospec is measured differently than its book value, which is the value of Innospec that is recorded on the company's balance sheet. Investors also form their own opinion of Innospec's value that differs from its market value or its book value, called intrinsic value, which is Innospec's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innospec's market value can be influenced by many factors that don't directly affect Innospec's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innospec's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innospec is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innospec's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.